Hadean Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Actitheraactithera.cominJul 2025 · $75.5M
Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Darshan Dalal(Chief Medical Officer)in
Co-investorsM VenturesSofinnova Partners4BIO CapitalBioqube Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.